Abstract 2629: Genome-informed therapy for osteosarcoma.

Leanne Sayles, Marcus Breeese, Amanda Koehne, Bogdan Tanasa, Stanley Leung, Alex Lee, Avanthi Shah, krystal Straessler, Kim Hazard, Mi-Ok Kim, Alejandro Sweet-Cordero

Abstract 4362: Identification of novel combinatorial synthetic lethal vulnerabilities in KRAS-driven lung cancer.

Kaja Kostyrko, Marcus R. Kelly, Kyuho Han, Edwin E. Jeng, David W. Morgens, Michael C. Bassik, Peter K. Jackson, Alejandro Sweet-Cordero

Abstract 2629: Genome-informed therapy for osteosarcoma.

Leanne Sayles, Marcus Breeese, Amanda Koehne, Bogdan Tanasa, Stanley Leung, Alex Lee, Avanthi Shah, krystal Straessler, Kim Hazard, Mi-Ok Kim, Alejandro Sweet-Cordero

Abstract 4362: Identification of novel combinatorial synthetic lethal vulnerabilities in KRAS-driven lung cancer.

Kaja Kostyrko, Marcus R. Kelly, Kyuho Han, Edwin E. Jeng, David W. Morgens, Michael C. Bassik, Peter K. Jackson, Alejandro Sweet-Cordero

Abstract B05: Preclinical evaluation of genome-informed therapy for osteosarcoma using patient-derived xenografts.

Leanne Sayles, Marcus Breese, Amanda Koehne, Leung Stan, Marina Neyssa, Spunt Sheri, Lee Alex, Aviv Spillinger, Steve Dubois, Rafi Avedian, Doug Hawkins, Mohler David, Alejandro Sweet-Cordero

Abstract B05: Preclinical evaluation of genome-informed therapy for osteosarcoma using patient-derived xenografts.

Leanne Sayles, Marcus Breese, Amanda Koehne, Leung Stan, Marina Neyssa, Spunt Sheri, Lee Alex, Aviv Spillinger, Steve Dubois, Rafi Avedian, Doug Hawkins, Mohler David, Alejandro Sweet-Cordero

Abstract PR03: Linking AP/MS-driven protein-protein interaction networks and combination CRISPR/sgRNA screens defines new Kras effectors and target candidates for non-small cell lung cancer.

Marcus R. Kelly, Han Kyuho, Edwin E. Jeng, David Morgans, Kaja Kostyrko, David Simpson, Dana Gwinn, Alejandro Sweet-Cordero, Michael C. Bassik, Peter K. Jackson

Abstract A27: Identification of novel KRAS-synthetic lethal targets for treatment of KRAS-dependent Non-Small Cell Lung Cancer.

Kaja Kostyrko, David Simpson, Joshua Broyde, Marcus Kelly, Andrea Califano, Barry Honig, Peter Jackson, Alejandro Sweet-Cordero

Abstract PR03: Linking AP/MS-driven protein-protein interaction networks and combination CRISPR/sgRNA screens defines new Kras effectors and target candidates for non-small cell lung cancer.

Marcus R. Kelly, Han Kyuho, Edwin E. Jeng, David Morgans, Kaja Kostyrko, David Simpson, Dana Gwinn, Alejandro Sweet-Cordero, Michael C. Bassik, Peter K. Jackson

Abstract A27: Identification of novel KRAS-synthetic lethal targets for treatment of KRAS-dependent Non-Small Cell Lung Cancer.

Kaja Kostyrko, David Simpson, Joshua Broyde, Marcus Kelly, Andrea Califano, Barry Honig, Peter Jackson, Alejandro Sweet-Cordero

Pages